AR213396A1 - Procedimiento para la preparacion de polimeros terapeuticamente activos que tienen un peso molecular en la gama de 1.000 a 1.500.000 - Google Patents

Procedimiento para la preparacion de polimeros terapeuticamente activos que tienen un peso molecular en la gama de 1.000 a 1.500.000

Info

Publication number
AR213396A1
AR213396A1 AR260799A AR26079975A AR213396A1 AR 213396 A1 AR213396 A1 AR 213396A1 AR 260799 A AR260799 A AR 260799A AR 26079975 A AR26079975 A AR 26079975A AR 213396 A1 AR213396 A1 AR 213396A1
Authority
AR
Argentina
Prior art keywords
procedure
preparation
range
molecular weight
therapeutically active
Prior art date
Application number
AR260799A
Other languages
English (en)
Spanish (es)
Original Assignee
Ferruti Paolo
Paoletti R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferruti Paolo, Paoletti R filed Critical Ferruti Paolo
Application granted granted Critical
Publication of AR213396A1 publication Critical patent/AR213396A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/14—Esterification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/10—Acylation
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • C08G81/02—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers at least one of the polymers being obtained by reactions involving only carbon-to-carbon unsaturated bonds
AR260799A 1974-10-15 1975-10-15 Procedimiento para la preparacion de polimeros terapeuticamente activos que tienen un peso molecular en la gama de 1.000 a 1.500.000 AR213396A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT28419/74A IT1044797B (it) 1974-10-15 1974-10-15 Alti polimeri contenenti radicali prostaglandinici processo per la loro preparazione e loro impiego

Publications (1)

Publication Number Publication Date
AR213396A1 true AR213396A1 (es) 1979-01-31

Family

ID=11223564

Family Applications (1)

Application Number Title Priority Date Filing Date
AR260799A AR213396A1 (es) 1974-10-15 1975-10-15 Procedimiento para la preparacion de polimeros terapeuticamente activos que tienen un peso molecular en la gama de 1.000 a 1.500.000

Country Status (16)

Country Link
US (2) US4228152A (de)
JP (2) JPS51125497A (de)
AR (1) AR213396A1 (de)
AT (1) AT343899B (de)
BE (1) BE834538A (de)
CA (1) CA1050035A (de)
CH (1) CH618190A5 (de)
DE (2) DE2546240A1 (de)
DK (1) DK461975A (de)
ES (1) ES441756A1 (de)
FR (2) FR2287913A1 (de)
GB (2) GB1513410A (de)
IN (1) IN142957B (de)
IT (1) IT1044797B (de)
NL (1) NL161462C (de)
SE (1) SE7511468L (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2902955C2 (de) * 1979-01-22 1982-09-16 Escher Wyss AG, Zürich Durchbiegungseinstellwalze
DE2902956C2 (de) * 1979-01-23 1983-05-26 Escher Wyss AG, Zürich Beheizte Durchbiegungseinstellwalze
US4675182A (en) * 1983-02-12 1987-06-23 Bayer Aktiengesellschaft Complexes of prostaglandins
JPS60190722U (ja) * 1984-05-28 1985-12-17 いすゞ自動車株式会社 ワ−クピツチ送り装置
EP0172962A1 (de) * 1984-08-30 1986-03-05 Ono Pharmaceutical Co., Ltd. Prostaglandine
JPS6279113A (ja) * 1985-09-30 1987-04-11 Toyoda Gosei Co Ltd ホ−ス搬送装置
US4684698A (en) * 1986-05-02 1987-08-04 Gaf Corporation Water soluble multicomplex of chlorothiazide, furosemide and poly(N-vinyl-2-pyrrolidone)
EP0540580B1 (de) * 1990-07-26 1994-04-13 G.D. Searle & Co. Arzneimittel freisetzendes polymeres system
FR2707010B1 (de) * 1993-06-25 1995-09-29 Bio Merieux
ZA978537B (en) 1996-09-23 1998-05-12 Focal Inc Polymerizable biodegradable polymers including carbonate or dioxanone linkages.
US6890524B1 (en) 1997-04-04 2005-05-10 Monsanto Company Hydrolyzable delivery system using cross-linked polymeric resins as vehicles
WO1998044951A2 (en) * 1997-04-04 1998-10-15 Monsanto Company Hydrolysable delivery system using cross-linked polymeric resins as vehicles
US6471955B1 (en) 1997-04-04 2002-10-29 Pharmacia Corporation Ph-selective delivery system using crosslinked polymeric resins as vehicles
US6803438B1 (en) * 1999-09-08 2004-10-12 Polytherics Limited Uniform molecular weight polymers
WO2002010132A1 (fr) * 2000-07-31 2002-02-07 Bio Merieux Derive de succinimide utile en tant que monomere bifonctionnel polymerisable
US10113033B2 (en) 2013-03-08 2018-10-30 Polyactiva Pty Ltd Polymer conjugate for delivery of a bioactive agent
KR102210895B1 (ko) 2013-03-08 2021-02-02 폴리액티바 피티와이 리미티드 생리활성 물질의 전달을 위한 폴리머 결합체
US11207417B2 (en) 2017-03-14 2021-12-28 Polyactiva Pty Ltd Drug-polymer conjugate
US11696955B2 (en) 2017-03-14 2023-07-11 Polyactiva Pty Ltd Drug-polymer conjugate
CA3054084A1 (en) 2017-03-14 2018-09-20 Polyactiva Pty Ltd Biodegradable drug-polymer conjugate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB869149A (en) * 1958-09-16 1961-05-31 Clinical Products Ltd Liquid pharmaceutical compositions comprising compounds of ion exchange resins and therapeutic substances
FR1603393A (de) * 1967-12-27 1971-04-13
USRE28316E (en) 1968-09-03 1975-01-21 Entrapment compositions and processes
US3932656A (en) * 1970-09-10 1976-01-13 Alza Corporation Article of manufacture for instant release of anti-aggregation and non-thrombogenic agents to biological media
BE786747A (fr) * 1971-07-26 1973-01-26 Du Pont Copolymeres greffes statistiques de pivalolactones
US4062855A (en) * 1971-09-27 1977-12-13 University Of Washington Synthetic polymers furnishing controlled release of a biologically active component during degradation
US3898986A (en) * 1972-12-27 1975-08-12 Alza Corp Biotransformable intrauterine device
US3811444A (en) * 1972-12-27 1974-05-21 Alza Corp Bioerodible ocular device
US4145320A (en) * 1974-10-15 1979-03-20 Paolo Ferruti Polymers containing polyunsaturated acid radicals, process for their preparation and use thereof

Also Published As

Publication number Publication date
BE834538A (fr) 1976-02-02
US4228152A (en) 1980-10-14
FR2287913A1 (fr) 1976-05-14
SE7511468L (sv) 1976-04-20
JPS51125497A (en) 1976-11-01
FR2287914B1 (de) 1978-09-22
IN142957B (de) 1977-09-10
FR2287913B1 (de) 1980-05-23
DE2546241A1 (de) 1976-04-29
NL161462C (nl) 1980-02-15
GB1524224A (en) 1978-09-06
GB1513410A (en) 1978-06-07
US4223011A (en) 1980-09-16
AT343899B (de) 1978-06-26
DE2546240A1 (de) 1976-04-29
CA1050035A (en) 1979-03-06
ATA787075A (de) 1977-10-15
CH618190A5 (de) 1980-07-15
NL7512106A (nl) 1976-04-21
JPS51125254A (en) 1976-11-01
JPS543788B2 (de) 1979-02-27
FR2287914A1 (fr) 1976-05-14
ES441756A1 (es) 1977-04-01
IT1044797B (it) 1980-04-21
NL161462B (nl) 1979-09-17
DK461975A (da) 1976-04-16

Similar Documents

Publication Publication Date Title
AR213396A1 (es) Procedimiento para la preparacion de polimeros terapeuticamente activos que tienen un peso molecular en la gama de 1.000 a 1.500.000
SE7507414L (sv) Galenisk beredning.
DK128675A (de) Pharmazeutische zusammensetzung
AR193590A1 (es) Procedimiento para la preparacion de 2,2'-metilendifenoles sustituidos
FR2283913A1 (fr) Polymeres phosphores et eventuellement azotes, utilisables dans la preparation de polyurethannes ignifuges
AR193840A1 (es) Un procedimiento para la preparacion de compuestos de 2-alquil-2-alquilamino-2',6'-acetoxilidida
NL7505240A (nl) Farmaceutisch preparaat.
AR210998A1 (es) Un procedimiento para la preparacion de acidos 7-acil 3-5-oxo -6- hidroxi -4, 5- dihidro -1, 2, 4- triazin -3il-tiometil -3-cefem -4- carboxilicos.
IT1046877B (it) Trifevil 1.2.3. triazolil i metani procedimento per la loro preparazione e loro impiego come fugicida
NL7411968A (nl) Moeilijk ontvlambare en zelfdovende vormmassa's.
NL7608211A (nl) Polytriazinen met een groot moleculair gewicht uit oplosbare polymere n-cyaaniso- ureumethers.
IT1024405B (it) Procedimento per la preparazione di polietilene con peso molecolare superiore a 500.000
AR211100A1 (es) Procedimiento para la preparacion de 3-metilpirazol-5-carboxilatos.
BE832498A (fr) 2,3-dihydro-oestra-1,3,5 (10)-trieno-(16alpha,17alpha,-beta) furan-17 beta-ols
IT1007885B (it) Poliacrilonitrili con basso peso molecolare e procedimento per la loro preparazione
FR2285871A1 (fr) Compositions pharmaceutiques
MX5355E (es) Procedimiento para la preparacion del hemicetal 3 a alfa-h-4-alfa(3'-propanol)-7-a beta-metilhexahidro-1,5-indandiona
AR213411A1 (es) Procedimiento para la preparacion de 2,6-metano-benzazocinas
BE772208A (fr) Polyesters d'acides dicarboxyliques a chaine ramifiee saturee, leur preparation et leurs emplois
NL7501798A (nl) Geneesmiddel tegen dehydratie bij dieren.
AR208532A1 (es) Un procedimiento para la preparacion de derivados de 3,4,6-tri-0-alcanoilo inferior-2-deoxi-2-nicotinamido-1-0-nicotinoil-glucopiranosa
FR2282271A1 (fr) Sels d'amoxycilline, utiles comme medicaments
MX4718E (es) Procedimiento para la preparacion de 2-tetrahidrofurfuril-6,7-benzomorfanos disubstituidos en 5,9-beta
BE812973A (fr) Compositions pharmaceutiques utiles en gastro-enterologie
AR201121A1 (es) Procedimiento para la preparacion de 2,2'-anhidro-1beta-d-arabinofuranosil-5-fluorocitosina